Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Homeobox protein Hox-D12 is a sequence-specific transcription factor encoded by the HOXD12 gene. It is part of the homeobox family, highly conserved genes responsible for regulating morphogenesis in multicellular organisms. HOXD12 operates as part of a developmental regulatory system that imparts specific positional information to cells along the anterior-posterior (head to tail) axis during embryogenesis, fundamentally influencing limb and skeletal development. Deletions affecting HOXD12 or its gene cluster can cause severe developmental abnormalities, especially involving limbs and genitalia[1][2][7]. There are no documented small molecule drugs or therapeutic interventions directly targeting HOXD12, as its main clinical relevance relates to developmental genetics and birth defects.
Not applicable; no drugs targeting this specific molecule are documented
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Homeobox protein Hox-D12 (HOXD12).